MedPath

Influence of an acidic beverage on the absorption of erlotinib

Completed
Conditions
lungcancer
Registration Number
NL-OMON24483
Lead Sponsor
Erasmus University Medical Center
Brief Summary

van Leeuwen et al. Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer. J Clin Oncol. 2016;34(12):1309-14

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

1. Age > 18 years

2. Use of Erlotinib monotherapy for at least 4 weeks

Exclusion Criteria

1. Age < 18 years

2. Pregnant or lactating patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in erlotinib bioavailability during coca-cola intake vs. water intake (+/- PPI)
Secondary Outcome Measures
NameTimeMethod
Toxicity of erlotinib
© Copyright 2025. All Rights Reserved by MedPath